SCHEMBL7966088

SCHEMBL7966088

CC(C)c1cc(OCC(=O)O)c2c3c(C(N)=O)cccc3n(Cc3cccc(-c4ccccc4)c3)c2c1

nearest known ligand 0.56

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 18/20 0.56
PLA2G1B P04054 11/20 0.56
PLA2G10 O15496 8/20 0.48
PLA2G2E Q9NZK7 7/20 0.48
PLA2G2F Q9BZM2 4/20 0.48
PLA2G2D Q9UNK4 4/20 0.48
PLA2G5 P39877 6/20 0.47
PLA2G6 O60733 1/20 0.46
PLA2G2C Q5R387 1/20 0.46
PLA2G12B Q9BX93 1/20 0.46
PLA2G12A Q9BZM1 1/20 0.46
PLA2G3 Q9NZ20 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL818386 0.94 PLA2G10 (0.52) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G2F
SCHEMBL29862319 0.94 PLA2G10 (0.52) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G2F
SCHEMBL7954036 0.91 PLA2G2A (0.46) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G2F
SCHEMBL7954950 0.90 PLA2G2A (0.47) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G2F
SCHEMBL7954113 0.90 PLA2G2A (0.45) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G2F
SCHEMBL7954937 0.90 PLA2G2A (0.45) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G2F
SCHEMBL7967128 0.90 PLA2G2A (0.46) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G2F
SCHEMBL7954705 0.90 PLA2G2A (0.58) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G2F
SCHEMBL7970461 0.90 PLA2G2A (0.44) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G2F
SCHEMBL7965984 0.89 PLA2G2A (0.59) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G2F

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6177440-B1 THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR ELI LILLY AND COMPANY 2001-01-23 US disclosed